Identification of tumor-specific T cell receptors of primary tumor-infiltrating lymphocytes (TILs) from B16F10 melanoma-bearing mice at single cell levels

被引：0
|
作者：
Shitaoka, K. [1 ]
Hamana, H. [1 ]
Kishi, H. [1 ]
Ozawa, T. [1 ]
Muraguchi, A. [1 ]
机构：
[1] Toyama Univ, Toyama, Japan
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2016年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
14
引用
收藏
页码：124 / 124
页数：1
相关论文
共 50 条
  • [1] Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures
    Li, Zhilang
    Ma, Lisha
    Gao, Zhaoya
    Wang, Xiya
    Che, Xuan
    Zhang, Pengchong
    Li, Yixian
    Zhang, Qianjing
    Liu, Tianxing
    Sun, Yuan
    Bai, Yun
    Deng, Hongkui
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (09)
  • [2] Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes
    Gee, Marvin H.
    Han, Arnold
    Lofgren, Shane M.
    Beausang, John F.
    Mendoza, Juan L.
    Birnbaum, Michael E.
    Bethune, Michael T.
    Fischer, Suzanne
    Yang, Xinbo
    Gomez-Eerland, Raquel
    Bingham, David B.
    Sibener, Leah V.
    Fernandes, Ricardo A.
    Velasco, Andrew
    Baltimore, David
    Schumacher, Ton N.
    Khatri, Purvesh
    Quake, Stephen R.
    Davis, Mark M.
    Garcia, K. Christopher
    CELL, 2018, 172 (03) : 549 - +
  • [3] Tumor-Reactive T Cell Receptors Identified by Multimodal Single-Cell Sequencing of Tumor-Infiltrating Lymphocytes
    Tan, Chin Leng
    Lindner, Katharina
    Green, Edward W.
    Bunse, Lukas
    Ratliff, Miriam
    Haltenhof, Gordon
    Poschke, Isabel
    Platten, Michael
    MOLECULAR THERAPY, 2022, 30 (04) : 168 - 168
  • [4] AUTOLOGOUS TUMOR-SPECIFIC CYTOTOXICITY OF TUMOR-INFILTRATING LYMPHOCYTES DERIVED FROM HUMAN RENAL-CELL CARCINOMA
    KOO, AS
    TSO, CL
    SHIMABUKURO, T
    PEYRET, C
    DEKERNION, JB
    BELLDEGRUN, A
    JOURNAL OF IMMUNOTHERAPY, 1991, 10 (05) : 347 - 354
  • [5] CHARACTERIZATION OF AUTOLOGOUS TUMOR-SPECIFIC T-HELPER-2 CELLS IN TUMOR-INFILTRATING LYMPHOCYTES FROM A PATIENT WITH METASTATIC MELANOMA
    KHARKEVITCH, DD
    SEITO, D
    BALCH, GC
    MAEDA, T
    BALCH, CM
    ITOH, K
    INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (03) : 317 - 323
  • [6] A Data Mining Architecture for Studying Cytokine Production and T Cell Repertoire of Tumor-Specific T Cells Generated from Tumor-Infiltrating Lymphocytes
    Siebert, Janet C.
    Puri, Sachin
    Moudgil, Tarsem
    Miller, William
    Walker, Edwin B.
    Bifulco, Carlo
    Curti, Brendan D.
    Urba, Walter J.
    Fox, Bernard A.
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (08) : 864 - 865
  • [7] Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell Analysis
    Shitaoka, Kiyomi
    Hamana, Hiroshi
    Kishi, Hiroyuki
    Hayakawa, Yoshihiro
    Kobayashi, Eiji
    Sukegawa, Kenta
    Piao, Xiuhong
    Lyu, Fulian
    Nagata, Takuya
    Sugiyama, Daisuke
    Nishikawa, Hiroyoshi
    Tanemura, Atsushi
    Katayama, Ichiro
    Murahashi, Mutsunori
    Takamatsu, Yasushi
    Tani, Kenzaburo
    Ozawa, Tatsuhiko
    Muraguchi, Atsushi
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (04) : 378 - 388
  • [8] TUMOR-INFILTRATING REGULATORY T CELLS FAVOR TUMOR DEVELOPMENT BY SUPPRESSING LOCAL TUMOR-SPECIFIC T CELL RESPONSES IN PRIMARY AND METASTATIC LIVER CANCER
    Pedroza-Gonzalez, A.
    Verhoef, C.
    Ijzermans, J. N.
    Peppelenbosch, M.
    Kwekkeboom, J.
    Janssen, H. L.
    Sprengers, D.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S126 - S126
  • [9] Effective tumor immunity to melanoma mediated by B16F10 cancer stem cell vaccine
    Zhao, Fengshu
    Zhang, Rong
    Wang, Jing
    Wu, Di
    Pan, Meng
    Li, Miao
    Guo, Mei
    Dou, Jun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 52 : 238 - 244
  • [10] Effective adoptive transfer of haploidentical tumor-specific T cells in B16-melanoma bearing mice
    Cui Nai-peng
    Xie Shao-jian
    Han Jin-sheng
    Ma Zhen-feng
    Chen Bao-ping
    Cai Jian-hui
    CHINESE MEDICAL JOURNAL, 2012, 125 (05) : 794 - 800
12345